| Product Code: ETC7214516 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France CNV (Choroidal NeoVascularization) Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, 2021 & 2031F |
3.3 France CNV (Choroidal NeoVascularization) Market - Industry Life Cycle |
3.4 France CNV (Choroidal NeoVascularization) Market - Porter's Five Forces |
3.5 France CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 France CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 France CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 France CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 France CNV (Choroidal NeoVascularization) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration, a major cause of choroidal neovascularization, in the aging population. |
4.2.2 Technological advancements in diagnostic tools and treatment options leading to improved outcomes. |
4.2.3 Rising awareness and early detection programs for eye diseases driving demand for CNV treatments. |
4.3 Market Restraints |
4.3.1 High cost associated with CNV treatments and therapies limiting accessibility for some patients. |
4.3.2 Stringent regulatory requirements for approval of new CNV treatments impacting market growth. |
4.3.3 Limited availability of skilled ophthalmologists specializing in CNV treatment leading to constrained treatment capacity. |
5 France CNV (Choroidal NeoVascularization) Market Trends |
6 France CNV (Choroidal NeoVascularization) Market, By Types |
6.1 France CNV (Choroidal NeoVascularization) Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Fluorescein AngiographyOptical Coherence Tomography, 2021- 2031F |
6.1.4 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 France CNV (Choroidal NeoVascularization) Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Anti-VEGF, 2021- 2031F |
6.2.3 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Photodynamic Therapy, 2021- 2031F |
6.2.4 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Thermal Laser, 2021- 2031F |
6.2.5 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 France CNV (Choroidal NeoVascularization) Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 France CNV (Choroidal NeoVascularization) Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By online Pharmacies, 2021- 2031F |
6.4.5 France CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
7 France CNV (Choroidal NeoVascularization) Market Import-Export Trade Statistics |
7.1 France CNV (Choroidal NeoVascularization) Market Export to Major Countries |
7.2 France CNV (Choroidal NeoVascularization) Market Imports from Major Countries |
8 France CNV (Choroidal NeoVascularization) Market Key Performance Indicators |
8.1 Average waiting time for CNV treatment appointments. |
8.2 Number of research studies and clinical trials focused on CNV treatments. |
8.3 Patient satisfaction rates with CNV treatment outcomes. |
8.4 Adoption rate of innovative CNV treatment technologies. |
8.5 Rate of recurrence of CNV post-treatment. |
9 France CNV (Choroidal NeoVascularization) Market - Opportunity Assessment |
9.1 France CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 France CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 France CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 France CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 France CNV (Choroidal NeoVascularization) Market - Competitive Landscape |
10.1 France CNV (Choroidal NeoVascularization) Market Revenue Share, By Companies, 2024 |
10.2 France CNV (Choroidal NeoVascularization) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here